Showing results (461-470 of 481) with videos related to
Sort By:
Pageof 49
JAMA Network Open|June 25, 2020
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical TrialSpyridon G Deftereos, Georgios Giannopoulos, Dimitrios A Vrachatis, et al.Revista Espanola De Cardiologia (English Ed.)|May 21, 2019
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fractionSergio Raposeiras-Roubín, Emad Abu-Assi, María Cespón-Fernández, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 8, 2017
Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registryGiorgio Quadri, Fabrizio D'Ascenzo, Claudio Moretti, et al.European Heart Journal. Acute Cardiovascular Care|June 9, 2017
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudyMario Iannaccone, Fabrizio D'Ascenzo, Paolo Vadalà, et al.Thrombosis and Haemostasis|April 4, 2018
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS RegistryAlberto Garay, Albert Ariza-Solé, Francesc Formiga, et al.Thrombosis Research|August 2, 2018
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-studyKajetan Grodecki, Zenon Huczek, Piotr Scisło, et al.American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.International Journal of Cardiology|February 7, 2018
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS scoreSergio Raposeiras-Roubín, Jonas Faxén, Andrés Íñiguez-Romo, et al.Pageof 49